Beyond biomarkers: the role of clinical factors associated with biologic therapy response in severe asthma
{{output}}
Background: Severe asthma carries a high burden and often requires biologic therapy targeting type 2 (T2) inflammation. However, treatment response is heterogeneous, and traditional biomarkers, such as blood eosinophils, fraction... ...
